The Lancet Oncology in conversation with (The Lancet Group)
Explore every episode of The Lancet Oncology in conversation with
| Pub. Date | Title | Duration | |
|---|---|---|---|
| 28 Feb 2022 | Rosie Bradley on early-stage breast cancer treatment | 00:04:33 | |
Rosie Bradley (Oxford Population Health, University of Oxford, Oxford, UK) discusses her Article on aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Mar 2022 | Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors | 00:12:53 | |
Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Apr 2022 | Georgios Lyratzopoulos on emergency presentation | 00:13:44 | |
Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission. Tell us what you thought about this episode Continue this conversation on social! | |||
| 09 May 2022 | Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa | 00:30:55 | |
Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Jun 2022 | David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer | 00:05:19 | |
David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe. Tell us what you thought about this episode Continue this conversation on social! | |||
| 25 Jul 2022 | Ignace Vergote and Maria Kyrgiou on gynaecological cancers | 00:10:30 | |
Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Aug 2022 | Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer | 00:11:39 | |
Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs. Tell us what you thought about this episode Continue this conversation on social! | |||
| 27 Sep 2022 | Inge Marie Svane on mRNA vaccines for cancer treatment | 00:08:11 | |
Inge Marie Svane (Copenhagen University Hospital, Copenhagen, Denmark) discusses her Review on clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Oct 2022 | Samar Alhomoud on challenges for cancer control in the Gulf region | 00:11:27 | |
Samar Alhomoud (King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) discusses her review on progress and remaining challenges for cancer control in the Gulf Cooperation Council. Tell us what you thought about this episode Continue this conversation on social! | |||
| 15 Nov 2022 | Mark Lawler and Richard Sullivan on the European Groundshot | 00:23:20 | |
Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Nov 2022 | Shankar Siva on radiotherapy for primary renal cell carcinoma | 00:08:30 | |
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Jan 2023 | Sameer Bakhshi on sex disparities in childhood cancer in India | 00:23:02 | |
Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Jan 2023 | Valerie Speirs on biomarkers in male breast cancer | 00:17:40 | |
Prof Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Feb 2023 | Janet Brown on the phase 2/3 STAR trial | 00:20:43 | |
Prof Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 27 Mar 2023 | Mark Lythgoe on UK oncology drug approval after Brexit | 00:14:11 | |
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit". Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 May 2023 | Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children | 00:28:40 | |
Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 May 2023 | Madeline Pe on the SISAQOL initiative | 00:14:01 | |
Madeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Jul 2023 | Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma | 00:33:50 | |
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Aug 2023 | Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA | 00:12:31 | |
Xuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Sep 2023 | Ticiana Leal on Tumour Treating Fields | 00:09:01 | |
Ticiana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Oct 2023 | Wanda Cui on measuring ovarian toxicity | 00:10:37 | |
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Oct 2023 | Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma | 00:17:10 | |
Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Nov 2023 | Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery | 00:43:49 | |
Dr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Nov 2023 | Neerja Bhatla on a new quadrivalent HPV vaccine | 00:12:24 | |
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Jan 2024 | Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma | 00:13:53 | |
Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Jan 2024 | Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer | 00:16:06 | |
Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’ Tell us what you thought about this episode Continue this conversation on social! | |||
| 26 Feb 2024 | Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers | 00:34:43 | |
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia. Tell us what you thought about this episode Continue this conversation on social! | |||
| 07 Mar 2024 | Maria Kyrgiou on innovations in gynaecological cancers and global disparities | 00:25:42 | |
In a special episode on International Women's Day 2024, we speak with Dr Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care. Tell us what you thought about this episode Continue this conversation on social! | |||
| 08 Apr 2024 | Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials | 00:11:22 | |
Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Apr 2024 | James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean | 00:35:05 | |
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico), and Dr Leticia Nogueira (American Cancer Society, Georgia, USA) discuss their Personal View entitled, ‘Protecting Caribbean patients diagnosed with cancer from compounding disasters. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 May 2024 | Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment | 00:24:08 | |
Dr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it. Tell us what you thought about this episode Continue this conversation on social! | |||
| 24 Jun 2024 | Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations | 00:36:56 | |
Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Jul 2024 | Emmy Boerrigter on dose selection of novel anticancer drugs | 00:11:41 | |
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses. Tell us what you thought about this episode Continue this conversation on social! | |||
| 27 Aug 2024 | Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) | 00:13:22 | |
Dr Kanwal Raghav (Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) discusses his Article entitled, ‘Trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a randomised, multicentre, phase 2 trial’. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Sep 2024 | May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics | 00:40:45 | |
May Abdel-Wahab (Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria) and Andrew Scott (Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia) discuss The Lancet Oncology Commission on Radiotherapy and Theranostics. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Sep 2024 | Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination | 00:17:21 | |
Dr Zachary Zumsteg (Cedars-Sinai Medical Center, Los Angeles, CA, USA) discusses his Review on the challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Oct 2024 | Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma | 00:15:07 | |
Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Dec 2024 | M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries | 00:22:15 | |
Professor M Saiful Huq (Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, USA) and Dr Mostafa Aziz Sumon (Radiation Oncology, Kurmitola General Hospital, Dhaka, Bangladesh) discuss their Series on Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Jan 2025 | Yannick Romero on the changing landscape of national cancer control plans | 00:24:40 | |
Dr Yannick Romero (Union for International Cancer Control) discusses his Policy Review on the changing landscape of the national cancer control plans and his work with the international cancer control partnership. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Feb 2025 | Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials | 00:18:03 | |
Professor Ian Tannock (Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada) discusses his Policy Review on Common Sense Oncology principles for the design, analysis and reporting of phase 3 randomised clinical trials. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Mar 2025 | Ariana Znaor on cancer surveillance in the Eastern Mediterranean region | 00:20:03 | |
Ariana Znaor (Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France) discusses her Review on cancer surveillance in the Eastern Mediterranean Region: a 10-year IARC-WHO EMRO collaboration. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Mar 2025 | Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA) | 00:07:33 | |
Professor Amar U. Kishan (Department of Radiation Oncology, University of California, Los Angeles, CA, USA) discusses his paper on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA): An Individual Patient Data Meta-Analysis of Randomised Trials in the MARCAP Consortium. Read the full article: Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Nov 2020 | The effect of climate change on cancer control | 00:11:47 | |
Robert Hiatt (University of California San Francisco, USA) discusses his and Naomi Beyeler’s (same University) Review on climate change and cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 16 Nov 2020 | The crucial role of oncology nurses in cancer care | 00:26:50 | |
Annie Young (University of Warwick, UK) and Julia Challinor (University of California San Francisco, USA) present their two-paper Series on Oncology Nursing. Tell us what you thought about this episode Continue this conversation on social! | |||
| 21 Jan 2021 | Sathira Perera on global cancer surgery | 00:07:47 | |
Sathira Perera (University of New South Wales, Australia) discusses his (and colleagues) Articles on the global use of cancer surgery. Tell us what you thought about this episode Continue this conversation on social! | |||
| 04 Jan 2021 | Short-course radiotherapy for advanced rectal cancer | 00:06:39 | |
Geke Hospers (University Medical Center Groningen, The Netherlands) discusses the RAPIDO trial Article published in The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Mar 2021 | Ariana Znaor on breast and cervical cancer in the former Soviet Union | 00:09:44 | |
Ariana Znaor, International Agency for Research on Cancer, discusses her Article on breast and cervical cancers stage distributions in ten newly independent states of the former Soviet Union. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Mar 2021 | Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine | 00:28:10 | |
Hedvig Hricak (Memorial Sloan Kettering Cancer Center), Andrew Scott (Olivia Newton-John Cancer Research Institute), Rifat Atun (Harvard TH Chan School of Public Health), and May Abdel-Wahab (International Atomic Energy Agency) discuss the latest Lancet Oncology’s Commission on Medical Imaging and Nuclear Medicine. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Apr 2021 | Roberto Orecchia on the ELIOT trial | 00:06:44 | |
Roberto Orecchia (European Institute of Oncology IRCCS) discusses the ELIOT trial on intraoperative irradiation for early breast cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Jun 2021 | Takayuki Yoshino on the DESTINY-CRC01 trial | 00:05:49 | |
Takayuki Yoshino (National Cancer Center Hospital East, Kashiwa, Japan) discusses the DESTINY-CRC01 trial on trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Jun 2021 | Rafael Cardoso and Hermann Brenner on colorectal cancer | 00:06:41 | |
Rafael Cardoso and Hermann Brenner (German Cancer Research Center, Heidelberg, Germany) discuss their recent paper on colorectal cancer incidence, mortality, and stage distribution in Europe. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Jul 2021 | Harriet Rumgay on the burden of cancer attributable to alcohol | 00:06:45 | |
Harriet Rumgay (International Agency for Research on Cancer, France) discusses the recent global burden of cancer in 2020 attributable to alcohol consumption study. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Aug 2021 | Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs | 00:28:02 | |
Susannah Stanway (UK Global Cancer Network), Richard Cowan (Christie NHS Foundation Trust, UK), Danielle Rodin (Princess Margaret Cancer Centre, Canada), and Miriam Mutebi (Aga Khan University Hospital, Kenya) discuss the Global Cancer Control Networks Series on how high-income countries, particularly the UK and Canada, can help with cancer control in low-income and middle-income countries. Tell us what you thought about this episode Continue this conversation on social! | |||
| 27 Sep 2021 | Manju Sengar and Christopher Booth on essential cancer drugs | 00:11:55 | |
Manju Sengar (Tata Memorial Centre, India) and Christopher Booth (Queen’s University Cancer Research Institute, Canada) discuss their Article on the comparison between cancer drugs deemed essential by oncologists and those included in the WHO Essential Medicines List. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Nov 2021 | James Glasbey on the effect of lockdowns on cancer surgery | 00:07:12 | |
James Glasbey (UK NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK) discusses his Article on the effect of COVID-19 pandemic lockdowns on planned cancer surgery. Tell us what you thought about this episode Continue this conversation on social! | |||
| 04 Nov 2021 | David Pinato on cancer patients who recovered from SARS-CoV-2 infection | 00:08:33 | |
David Pinato (Imperial College London, Hammersmith Hospital, London, UK) discusses his Article on prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Nov 2021 | Aju Mathew on cancer care in India | 00:06:08 | |
Aju Mathew (Malankara Orthodox Syrian Church Medical College and Hospital, Kerala, India) discusses his Review on financial toxicity in cancer care in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Dec 2021 | Elysia Alvarez on adolescent and young adult cancer | 00:04:05 | |
Elysia Alvarez (UC Davis Comprehensive Cancer Center, Sacramento, USA) discusses her Article on the analysis of the global burden of adolescent and young adult cancer in 2019. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Jan 2022 | Rebecca Fitzgerald on Barrett's oesophagus surveillance | 00:07:25 | |
Rebecca Fitzgerald (University of Cambridge, Cambridge, UK) discusses her Article on the use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Feb 2022 | Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer | 00:09:56 | |
Prof Yi-Long Wu (Guangdong Lung Cancer Institute, Guangzhou, China) and Prof Caicun Zhou (Shanghai Pulmonary Hospital, Shanghai, China) discuss the GEMSTONE 301 and GEMSTONE 302 trials on sugemalimab versus placebo in non-small-cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Sep 2016 | Renal surveillance: The Lancet Oncology: August 30, 2016 | 00:09:54 | |
Brian Rini discusses active surveillance for patients with metastatic renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Oct 2016 | Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016 | 00:11:23 | |
Brigitta Baumert discusses her article on quality of life in patients with high-risk, low-grade glioma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 05 Nov 2016 | Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016 | 00:13:15 | |
Rafael Rossell discusses RET inhibitors and non-small cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Dec 2016 | Cancer survivorship in the USA: The Lancet Oncology: 30 December | 00:11:22 | |
Ann Partridge talks about cancer survival in the USA. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Feb 2017 | Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017 | 00:15:46 | |
Javier Torres-Roca and Louis Harrison join us to discuss their work on genome modelling and its uses in calculating the appropriate radiation dosage. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Mar 2017 | Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017 | 00:18:17 | |
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Mar 2017 | <sup>18</sup>F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017 | 00:05:57 | |
Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias. Tell us what you thought about this episode Continue this conversation on social! | |||
| 26 Apr 2017 | Head and neck cancer Series: The Lancet Oncology: April 26, 2017 | 00:17:04 | |
Sandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer.
Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Jun 2017 | EANO and palliative care: The Lancet Oncology: June 2, 2017 | 00:08:57 | |
Martin Taphoorn outlines the importance of palliative care for patients with gliomas. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Jun 2017 | Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017 | 00:07:34 | |
Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 26 Jul 2017 | Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017 | 00:08:01 | |
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Sep 2017 | Cancer in Peru: The Lancet Oncology | 00:19:09 | |
Ben Anderson talks about cancer care and cancer trends in Peru. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Nov 2017 | Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017 | 00:10:45 | |
Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA. Tell us what you thought about this episode Continue this conversation on social! | |||
| 28 Nov 2017 | Lung cancer screening: The Lancet Oncology: November 27, 2017 | 00:10:29 | |
John Field discusses a European position statement on lung cancer screening using low-dose CT. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Dec 2017 | Trial design for brain metastases: The Lancet Oncology: Jan 2018 | 00:11:11 | |
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Aug 2018 | Changing incidence of adolescent cancer | 00:08:54 | |
Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents. Tell us what you thought about this episode Continue this conversation on social! | |||
| 31 Aug 2018 | Are patient reported outcomes consistent? | 00:08:04 | |
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Mar 2018 | Chromatin organisation and cancer prognosis | 00:07:24 | |
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 14 Aug 2018 | Diffuse intrinsic pontine glioma | 00:22:08 | |
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Jun 2018 | Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer | 00:09:49 | |
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 01 Jun 2018 | Gender and cancer immunotherapy efficacy | 00:09:37 | |
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Mar 2018 | Vulvar field resection | 00:13:54 | |
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields. Tell us what you thought about this episode Continue this conversation on social! | |||
| 25 Apr 2018 | PROs in regulatory decision making | 00:11:33 | |
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Nov 2018 | Cervical cancer screening in older women | 00:12:00 | |
Talía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 19 Oct 2018 | Palliative care in oncology | 00:10:25 | |
Stein Kaasa and Jon Loge discuss their new Commission on palliative care. Tell us what you thought about this episode Continue this conversation on social! | |||
| 27 Sep 2018 | Global review of cancer control | 00:10:34 | |
Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Apr 2019 | Choosing Wisely India | 00:12:33 | |
CS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 Aug 2019 | Advances in radioimmunotherapy | 00:13:50 | |
Eric Deutsch (Gustave Roussy Comprehensive Cancer Center, Villejuif, France) presents The Lancet Oncology’s latest series on advances in radioimmunotherapy for cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| 04 Dec 2019 | Global public and philanthropic investment in childhood cancer research | 00:14:11 | |
Rifat Atun (Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA) discusses a Review in The Lancet Oncology on global patterns in public and philanthropic funding for childhood cancer research with Senior Editor Márcia Costa. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Feb 2019 | Malignant plural mesothelioma | 00:20:20 | |
Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Jan 2019 | CAR T-cell therapy | 00:12:44 | |
Frederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 02 Jul 2019 | International Neoadjuvant Melanoma Consortium | 00:13:59 | |
Georgina Long (The University of Sydney, Sydney, NSW, Australia) discusses three papers from The Lancet Oncology on neoadjuvant approaches for melanoma treatment. Tell us what you thought about this episode Continue this conversation on social! | |||
| 05 Mar 2019 | Paediatric vertebral radiotherapy | 00:14:19 | |
Bianca Hoeben discusses the latest guidelines from the SIOPE radiotherapy working group on vertebral radiotherapy dose in paediatric patients. Tell us what you thought about this episode Continue this conversation on social! | |||
| 16 May 2019 | Digital oncology | 00:09:45 | |
Kee Yuan Ngiam (National University Hospital Singapore, Singapore) discusses a duo of papers exploring big data and machine-learning algorithms for healthcare delivery and pathology in oncology. Tell us what you thought about this episode Continue this conversation on social! | |||
| 30 Oct 2019 | Cervical cancer in India | 00:08:48 | |
Partha Basu (International Agency for Research on Cancer, Lyon, France) discusses a Policy Review in The Lancet Oncology on cervical cancer prevention efforts in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Oct 2019 | Oropharyngeal squamous cell carcinoma | 00:18:15 | |
David Palma and Anthony Nichols discuss the findings from their ORATOR trial on radiotherapy or robotic surgery for oropharyngeal squamous cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Sep 2019 | Cancer in small island nations | 00:07:45 | |
New Zealand’s new interim Cancer Control Agency director, Diana Sarfati, discusses a series of five papers exploring cancer control in small island nations. Tell us what you thought about this episode Continue this conversation on social! | |||
| 29 May 2019 | IMWG consensus on imaging in plasma cell disorders | 00:07:04 | |
Jens Hillengass discusses the new International Myeloma Working Group consensus guidelines on optimal use of imaging methods for monoclonal plasma cell disorders. Tell us what you thought about this episode Continue this conversation on social! | |||
| 03 Mar 2020 | International standards for the analysis of patient-reported outcomes in cancer trials | 00:11:38 | |
Corneel Coens and Madeline Pe discuss recommendations from the SISAQOL Consortium for the analysis of patient-reported outcomes, published in a Policy Review in The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! | |||
| 09 Jan 2020 | Presenting symptoms of cancer and stage at diagnosis | 00:06:59 | |
Monica Koo (University College London, London, UK) discusses an Article in The Lancet Oncology on presenting symptoms of cancer and stage at diagnosis in patients in England. Tell us what you thought about this episode Continue this conversation on social! | |||